Infectious Disease Research Institute (IDRI)

The Infectious Disease Research Institute is a new breed of global health nonprofit, taking a comprehensive approach to address infectious diseases.

The Institute combines the high-quality science of a research organization with the product development capabilities of a biotech company to create new diagnostics, drugs and vaccines.

IDRI is a bridge between knowledge and action. The Institute combines passion for improving human health with the understanding that it is not just what we know about disease, but what we do to change its course that will have the greatest impact. Developing products that solve intractable global health challenges is what they do, having a track record of doing it successfully. Their unique product-based approach to fighting infectious diseases has already yielded novel diagnostics, vaccines, and treatment strategies that are protecting and saving lives.

With deep relationships in the academic and corporate arenas, IDRI unites the best of the research and product development communities. IDRI's partnerships with businesses, nonprofit foundations, and government agencies give them unprecedented access to cutting-edge technology and financial support.
 

Euroleish.net involvement: Dr. Steven Reed is co-supervisor of project 2.5, providing training in inmunological and molecular techniques to identify novel antigens/combinations to be applied to population samples.


Projects

2.5 New methods to identify leishmania super-spreaders in modelling targeted control

INBios International, Inc., Seattle, USA - The University of Warwick (WARWICK), Coventry, United Kingdom - Infectious Disease Research Institute (IDRI), Seattle, USA